Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-06-18

Clinical Trial Update: Effect of Recombinant Human Brain Natriuretic Peptide on Ventricular Remodeling and Cardiac Function in Patients With Acute Anterior Myocardial Infraction Undergoing Percutaneous Coronary Intervention

View source ↗

Summary

This clinical trial evaluates whether recombinant human brain natriuretic peptide (rhBNP) can improve ventricular remodeling and cardiac function in patients wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nesiritide (recombinant human B-type natriuretic peptide (rhBNP))

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: Ventricular Remodeling, Myocardial Infarction, Anterior Wall | Status: RECRUITING